Trogocytosis in innate immunity to cancer is an intimate relationship with unexpected outcomes.

Biophysics cancer cell biology immunology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
21 Oct 2022
Historique:
received: 02 06 2022
revised: 04 08 2022
accepted: 07 09 2022
entrez: 3 10 2022
pubmed: 4 10 2022
medline: 4 10 2022
Statut: epublish

Résumé

Trogocytosis is a cellular process whereby a cell acquires a membrane fragment from a donor cell in a contact-dependent manner allowing for the transfer of surface proteins with functional integrity. It is involved in various biological processes, including cell-cell communication, immune regulation, and response to pathogens and cancer cells, with poorly defined molecular mechanisms. With the exception of eosinophils, trogocytosis has been reported in most immune cells and plays diverse roles in the modulation of anti-tumor immune responses. Here, we report that eosinophils acquire membrane fragments from tumor cells early after contact through the CD11b/CD18 integrin complex. We discuss the impact of trogocytosis in innate immune cells on cancer progression in the context of the evidence that eosinophils can engage in trogocytosis with tumor cells. We also discuss shared and cell-specific mechanisms underlying this process based on

Identifiants

pubmed: 36185368
doi: 10.1016/j.isci.2022.105110
pii: S2589-0042(22)01382-7
pmc: PMC9515589
doi:

Types de publication

Journal Article

Langues

eng

Pagination

105110

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Blood. 2012 May 31;119(22):5164-72
pubmed: 22498742
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W96-9
pubmed: 15215358
J Cell Sci. 1999 Oct;112 ( Pt 19):3289-97
pubmed: 10504334
Blood. 2009 Nov 5;114(19):4108-16
pubmed: 19749090
Immunity. 2011 Aug 26;35(2):208-22
pubmed: 21820331
Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16873-8
pubmed: 15550544
Adv Exp Med Biol. 2020;1273:1-28
pubmed: 33119873
Oncoimmunology. 2017 Nov 13;7(2):e1393134
pubmed: 29308325
Mol Cancer Ther. 2016 Aug;15(8):1879-89
pubmed: 27226489
J Exp Clin Cancer Res. 2022 Mar 14;41(1):97
pubmed: 35287686
Biomedicines. 2021 Dec 29;10(1):
pubmed: 35052746
Front Immunol. 2022 Feb 03;13:791006
pubmed: 35185886
PLoS One. 2008 Aug 29;3(8):e3097
pubmed: 18769733
Int Immunopharmacol. 2013 Nov;17(3):638-50
pubmed: 23994464
Cell Mol Immunol. 2012 Mar;9(2):136-46
pubmed: 22307040
J Immunol. 2014 Jan 15;192(2):824-32
pubmed: 24337377
Cell Rep. 2018 Jun 26;23(13):3946-3959.e6
pubmed: 29949776
PLoS Pathog. 2021 Aug 20;17(8):e1009868
pubmed: 34415956
J Leukoc Biol. 2008 Jan;83(1):1-12
pubmed: 17906117
Crit Rev Oncol Hematol. 2021 Dec;168:103541
pubmed: 34801696
Curr Opin Virol. 2017 Feb;22:89-96
pubmed: 28088123
J Immunol. 2007 Jul 1;179(1):337-45
pubmed: 17579054
Cancer Immunol Res. 2020 Oct;8(10):1287-1299
pubmed: 32759362
Eur J Immunol. 2002 May;32(5):1502-8
pubmed: 11981839
Am J Clin Exp Immunol. 2014 Feb 27;3(1):37-42
pubmed: 24660120
J Immunother Cancer. 2021 May;9(5):
pubmed: 34049929
Immunity. 2022 Jun 14;55(6):982-997.e8
pubmed: 35617964
J Clin Invest. 2022 May 2;132(9):
pubmed: 35316223
Blood. 2003 Jan 1;101(1):253-8
pubmed: 12485936
Proc Natl Acad Sci U S A. 2021 Jul 27;118(30):
pubmed: 34301886
Leukemia. 2020 Sep;34(9):2405-2417
pubmed: 32089543
J Protozool. 1990 Mar-Apr;37(2):138-44
pubmed: 2108243
Biochem Soc Symp. 1999;65:79-99
pubmed: 10320934
Int J Mol Sci. 2021 Feb 24;22(5):
pubmed: 33668117
J Immunol. 2015 Sep 1;195(5):2483-92
pubmed: 26216891
J Exp Med. 2001 Nov 19;194(10):1519-30
pubmed: 11714758
Eur Biophys J. 2021 Mar;50(2):223-237
pubmed: 33599795
Blood Adv. 2020 Jul 14;4(13):3128-3135
pubmed: 32649767
Front Cell Dev Biol. 2021 Feb 04;9:629097
pubmed: 33614660
J Exp Med. 2001 Nov 19;194(10):1531-9
pubmed: 11714759
J Immunol. 2008 Dec 1;181(11):8120-32
pubmed: 19018005
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1111-1116
pubmed: 28096423
Cancer Immunol Res. 2021 Oct;9(10):1229-1241
pubmed: 34326137
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9421-6
pubmed: 23690625
Proteins. 2006 Nov 1;65(2):392-406
pubmed: 16933295
Chem Phys Lipids. 2016 Sep;199:136-143
pubmed: 27179407
Blood Adv. 2022 Apr 12;6(7):2156-2166
pubmed: 34942000
Sci Adv. 2022 Apr 15;8(15):eabj3286
pubmed: 35417234
Immunity. 2011 Aug 26;35(2):151-3
pubmed: 21867922
Cancers (Basel). 2019 Oct 26;11(11):
pubmed: 31717819
Cells. 2021 May 19;10(5):
pubmed: 34069602
J Immunol. 2006 Nov 1;177(9):6018-24
pubmed: 17056526
EMBO J. 2015 May 12;34(10):1336-48
pubmed: 25787857
Nat Rev Mol Cell Biol. 2019 Jan;20(1):38-54
pubmed: 30323238
Proc Natl Acad Sci U S A. 2019 Nov 12;116(46):23143-23151
pubmed: 31591250
J Immunol. 2012 Jan 15;188(2):744-52
pubmed: 22174448
Clin Dev Immunol. 2013;2013:345745
pubmed: 24093044
Cell Rep. 2021 Aug 31;36(9):109632
pubmed: 34469729
J Cell Biol. 2014 Apr 28;205(2):265-81
pubmed: 24778313
Nat Immunol. 2003 Sep;4(9):815
pubmed: 12942076
Cells. 2021 Jun 12;10(6):
pubmed: 34204661
Cancer Immunol Res. 2021 Feb;9(2):147-155
pubmed: 33355195
Nat Rev Mol Cell Biol. 2008 Jul;9(7):543-56
pubmed: 18496517
Blood. 2015 Jan 29;125(5):762-6
pubmed: 25498911
Biomed Res Int. 2021 Sep 22;2021:1601565
pubmed: 34604381
Front Immunol. 2015 Jan 05;5:672
pubmed: 25601867
Cancer Res. 2008 Mar 15;68(6):2006-13
pubmed: 18339883
Nat Protoc. 2017 Feb;12(2):255-278
pubmed: 28079879
EMBO J. 2007 Mar 7;26(5):1423-33
pubmed: 17318190
Mol Cells. 2010 Apr;29(4):311-25
pubmed: 20446344
BMC Cancer. 2015 Feb 06;15:39
pubmed: 25655677
Mol Cancer Ther. 2020 Oct;19(10):2044-2056
pubmed: 32747419
PLoS One. 2012;7(12):e52918
pubmed: 23300821
Nature. 2011 Mar 31;471(7340):629-32
pubmed: 21455179
Proc Natl Acad Sci U S A. 1972 Sep;69(9):2556-60
pubmed: 4506774
Science. 2011 Apr 29;332(6029):600-3
pubmed: 21474713
J Immunol. 2006 Feb 15;176(4):2600-9
pubmed: 16456022
J Exp Med. 2001 Nov 19;194(10):1507-17
pubmed: 11714757
J Exp Med. 2017 Dec 4;214(12):3791-3811
pubmed: 29084819
Nature. 2019 Apr;568(7750):112-116
pubmed: 30918399
FASEB J. 2002 Apr;16(6):477-86
pubmed: 11919150
Blood. 2001 Apr 15;97(8):2478-86
pubmed: 11290613

Auteurs

Fabrizio Mattei (F)

Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.

Sara Andreone (S)

Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.

Francesca Spadaro (F)

Core Facilities, Microscopy Unit, Istituto Superiore di Sanità, Rome, Italy.

Francesco Noto (F)

Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.

Antonella Tinari (A)

Center for Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.

Mario Falchi (M)

National HIV/AIDS Research Center (CNAIDS), Istituto Superiore di Sanità, Rome, Italy.

Silvia Piconese (S)

Department of Internal Clinical Sciences, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Italy.
Neuroimmunology Unit, IRCCS Fondazione Santa Lucia, Rome, Italy.
Laboratory Affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome, Italy.

Claudia Afferni (C)

National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.

Giovanna Schiavoni (G)

Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.

Classifications MeSH